• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分支杆菌属-鸟复合种群物种在囊性纤维化中的感染分布和结果。

Distribution and outcomes of infection of Mycobacterium avium complex species in cystic fibrosis.

机构信息

Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.

Department of Statistics and Biostatistics, University of Michigan, Ann Arbor, MI, USA.

出版信息

J Cyst Fibros. 2020 Mar;19(2):232-235. doi: 10.1016/j.jcf.2019.07.007. Epub 2019 Aug 6.

DOI:10.1016/j.jcf.2019.07.007
PMID:31399327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7002288/
Abstract

BACKGROUND

The majority of nontuberculous mycobacterial (NTM) pulmonary infections in people with cystic fibrosis (CF) are caused by Mycobacterium avium complex (MAC) species. Data on MAC species distribution and outcomes of infection in CF are lacking.

METHODS

This was a single center, retrospective study. MAC isolates had species identification with MLSA of rpoB and the 16S23S ITS region. Clinical data were compared between species.

RESULTS

Twenty-three people with CF and 57 MAC isolates were included. Infection with M. avium was the most common (65.2%). M. intracellulare was associated with higher rates of NTM disease, younger age, and steeper decline in lung function prior to infection.

CONCLUSIONS

We observed worse clinical outcomes in people with M. intracellulare infection relative to other MAC species. Further investigation of clinical outcomes of MAC infection among CF patients is warranted to better define the utility of species-level identification of MAC isolates in CF.

摘要

背景

囊性纤维化(CF)患者中大多数非结核分枝杆菌(NTM)肺部感染是由鸟分枝杆菌复合群(MAC)物种引起的。关于 CF 中 MAC 物种分布和感染结局的数据尚缺乏。

方法

这是一项单中心回顾性研究。MAC 分离株采用 rpoB 和 16S23S ITS 区的 MLSA 进行种属鉴定。比较了不同种属之间的临床数据。

结果

共纳入 23 名 CF 患者和 57 株 MAC 分离株。最常见的感染是鸟分枝杆菌(65.2%)。细胞内分枝杆菌与更高的 NTM 疾病发生率、更年轻的年龄以及感染前肺功能下降更陡峭相关。

结论

与其他 MAC 物种相比,我们观察到细胞内分枝杆菌感染者的临床结局更差。进一步研究 CF 患者 MAC 感染的临床结局,以更好地确定 CF 中 MAC 分离株的种属鉴定的实用性是有必要的。

相似文献

1
Distribution and outcomes of infection of Mycobacterium avium complex species in cystic fibrosis.分支杆菌属-鸟复合种群物种在囊性纤维化中的感染分布和结果。
J Cyst Fibros. 2020 Mar;19(2):232-235. doi: 10.1016/j.jcf.2019.07.007. Epub 2019 Aug 6.
2
Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis.囊性纤维化和非囊性纤维化支气管扩张中的非结核分枝杆菌
Semin Respir Crit Care Med. 2015 Apr;36(2):217-24. doi: 10.1055/s-0035-1546751. Epub 2015 Mar 31.
3
Population Genomics and Inference of Mycobacterium avium Complex Clusters in Cystic Fibrosis Care Centers, United States.人群基因组学与美国囊性纤维化护理中心中鸟分枝杆菌复合体群的推断。
Emerg Infect Dis. 2021 Nov;27(11):2836-2846. doi: 10.3201/eid2711.210124.
4
Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations.鸟分枝杆菌和脓肿分枝杆菌复合体针对不同的囊性纤维化患者亚群。
J Cyst Fibros. 2013 Jan;12(1):74-80. doi: 10.1016/j.jcf.2012.06.009. Epub 2012 Jul 31.
5
[Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].[日本鸟分枝杆菌复合群感染控制策略:它们如何改善当前状况?]
Kekkaku. 2013 Mar;88(3):355-71.
6
Comparing the Genotype and Drug Susceptibilities between Mycobacterium avium and Mycobacterium intracellulare in China.中国鸟分枝杆菌与胞内分枝杆菌的基因型及药敏情况比较
Biomed Environ Sci. 2017 Jul;30(7):517-525. doi: 10.3967/bes2017.068.
7
Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012.2007年至2012年期间,肺部鸟分枝杆菌复合群是英格兰、威尔士和北爱尔兰非结核分枝杆菌发病率上升的主要驱动因素。
BMC Infect Dis. 2016 May 6;16:195. doi: 10.1186/s12879-016-1521-3.
8
[Non-tuberculous mycobacteriosis. What has been coming out].[非结核分枝杆菌病。最新进展]
Kekkaku. 2011 Feb;86(2):113-25.
9
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.法国囊性纤维化患者中非结核分枝杆菌流行情况的多中心研究。
J Clin Microbiol. 2009 Dec;47(12):4124-8. doi: 10.1128/JCM.01257-09. Epub 2009 Oct 21.
10
Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany.德国囊性纤维化患者中非结核分枝杆菌感染的流行病学趋势。
Int J Infect Dis. 2023 Apr;129:32-39. doi: 10.1016/j.ijid.2023.01.032. Epub 2023 Jan 31.

引用本文的文献

1
Series 1: The Use of 65- and (41)-Targeted Amplicon Sequencing in the Diagnostic Workflow for Non-Tuberculous Mycobacteria.系列1:65和(41)靶向扩增子测序在非结核分枝杆菌诊断流程中的应用
Trop Med Infect Dis. 2025 Jul 9;10(7):192. doi: 10.3390/tropicalmed10070192.
2
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
3
Broad-Spectrum In Vitro Activity of α-Aroyl--Aryl-Phenylalanine Amides against Non-Tuberculous Mycobacteria and Comparative Analysis of RNA Polymerases.α-芳酰基-α-芳基苯丙氨酸酰胺对非结核分枝杆菌的广谱体外活性及RNA聚合酶的比较分析
Antibiotics (Basel). 2024 Apr 28;13(5):404. doi: 10.3390/antibiotics13050404.
4
Comparative Genomics of Mycobacterium avium Complex Reveals Signatures of Environment-Specific Adaptation and Community Acquisition.鸟分枝杆菌复合群的比较基因组学揭示了环境特异性适应和群落获得的特征。
mSystems. 2021 Oct 26;6(5):e0119421. doi: 10.1128/mSystems.01194-21. Epub 2021 Oct 19.

本文引用的文献

1
Complex Diversity within Lung Disease, as Revealed by Whole-Genome Sequencing.全基因组测序揭示的肺部疾病复杂多样性
Am J Respir Crit Care Med. 2019 Aug 1;200(3):393-396. doi: 10.1164/rccm.201903-0669LE.
2
Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens.从呼吸道标本中分离出的鸟分枝杆菌复合群菌种的分布及临床意义
Diagn Microbiol Infect Dis. 2017 Jun;88(2):125-137. doi: 10.1016/j.diagmicrobio.2017.02.017. Epub 2017 Mar 2.
3
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.美国囊性纤维化基金会和欧洲囊性纤维化协会关于囊性纤维化患者非结核分枝杆菌管理的共识建议。
Thorax. 2016 Jan;71 Suppl 1(Suppl 1):i1-22. doi: 10.1136/thoraxjnl-2015-207360.
4
Comparison of Clinical Features, Virulence, and Relapse among Mycobacterium avium Complex Species.比较鸟分枝杆菌复合群种间的临床特征、毒力和复发情况。
Am J Respir Crit Care Med. 2015 Jun 1;191(11):1310-7. doi: 10.1164/rccm.201501-0067OC.
5
Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.囊性纤维化患者首次非结核分枝杆菌培养阳性的临床意义
Ann Am Thorac Soc. 2014 Jan;11(1):36-44. doi: 10.1513/AnnalsATS.201309-310OC.
6
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.从肺部样本中分离的非结核分枝杆菌的地理多样性:一项 NTM-NET 合作研究。
Eur Respir J. 2013 Dec;42(6):1604-13. doi: 10.1183/09031936.00149212. Epub 2013 Apr 18.
7
Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease.分枝杆菌复合群肺病中区分鸟分枝杆菌和胞内分枝杆菌的临床意义。
Chest. 2012 Dec;142(6):1482-1488. doi: 10.1378/chest.12-0494.
8
rpoB sequence-based identification of Mycobacterium avium complex species.基于rpoB序列的鸟分枝杆菌复合群菌种鉴定
Microbiology (Reading). 2008 Dec;154(Pt 12):3715-3723. doi: 10.1099/mic.0.2008/020164-0.
9
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.美国胸科学会/美国感染病学会官方声明:非结核分枝杆菌病的诊断、治疗与预防
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. doi: 10.1164/rccm.200604-571ST.
10
EMERSE: The Electronic Medical Record Search Engine.EMERSE:电子病历搜索引擎。
AMIA Annu Symp Proc. 2006;2006:941.